Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant

被引：10
|
作者：
Kovalenko, Angelina O. [1 ]
Ryabchevskaya, Ekaterina M. [1 ]
Evtushenko, Ekaterina A. [1 ]
Manukhova, Tatiana I. [1 ]
Kondakova, Olga A. [1 ]
Ivanov, Peter A. [1 ]
Arkhipenko, Marina V. [1 ]
Gushchin, Vladimir A. [1 ,2 ]
Nikitin, Nikolai A. [1 ]
Karpova, Olga V. [1 ]
机构：
[1] Lomonosov Moscow State Univ, Fac Biol, Dept Virol, Moscow, Russia
[2] Minist Hlth Russian Federat, NF Gamaleya Natl Res Ctr Epidemiol & Microbiol, Moscow, Russia
来源：
FRONTIERS IN MICROBIOLOGY | 2022年 / 13卷
基金：
俄罗斯基础研究基金会;
关键词：
coronaviruses; vaccine candidate; plant virus; adjuvant; tobacco mosaic virus; structurally modified plant virus; RECEPTOR-BINDING DOMAIN; TOBACCO-MOSAIC-VIRUS; SARS-COV-2; SPIKE; SPHERICAL-PARTICLES; SARS-COV; PROTEIN; MUTATIONS; INFECTION; EPITOPES; VIRIONS;
D O I：
10.3389/fmicb.2022.845316
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
A recombinant vaccine candidate has been developed based on the major coronaviruses' antigen (S protein) fragments and a novel adjuvant-spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling. The receptor-binding domain and the highly conserved antigenic fragments of the S2 protein subunit were chosen for the design of recombinant coronavirus antigens. The set of three antigens (Co1, CoF, and PE) was developed and used to create a vaccine candidate composed of antigens and SPs (SPs + 3AG). Recognition of SPs + 3AG compositions by commercially available antibodies against spike proteins of SARS-CoV and SARS-CoV-2 was confirmed. The immunogenicity testing of these compositions in a mouse model showed that SPs improved immune response to the CoF and PE antigens. Total IgG titers against both proteins were 9-16 times higher than those to SPs. Neutralizing activity against SARS-CoV-2 in serum samples collected from hamsters immunized with the SPs + 3AG was demonstrated.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] In Silico Discovery of Candidate Drugs against Covid-19
    Cava, Claudia
    Bertoli, Gloria
    Castiglioni, Isabella
    VIRUSES-BASEL, 2020, 12 (04):
  • [22] Various vaccine platforms in the field of COVID-19
    Savina, K.
    Sreekumar, Rakhy
    Soonu, V. K.
    Variyar, E. J.
    BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, 2022, 11 (01)
  • [23] Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections
    Ojha, Rupal
    Singh, Satyendra
    Gupta, Nidhi
    Kumar, Ketan
    Padhi, Aditya K.
    Prajapati, Vijay Kumar
    BIOTECHNOLOGY LETTERS, 2023, 45 (07) : 779 - 797
  • [24] Vaccine design and delivery approaches for COVID-19
    Shahzamani, Kiana
    Mahmoudian, Fatemeh
    Ahangarzadeh, Shahrzad
    Ranjbar, Mohammad Mehdi
    Beikmohammadi, Leila
    Bahrami, Samira
    Mohammadi, Elmira
    Esfandyari, Sahar
    Alibakhshi, Abbas
    Javanmard, Shaghayegh Haghjooy
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2021, 100
  • [25] Plant production of a virus-like particle-based vaccine candidate against porcine reproductive and respiratory syndrome
    VanderBurgt, Jordan T. T.
    Harper, Ondre
    Garnham, Christopher P. P.
    Kohalmi, Susanne E. E.
    Menassa, Rima
    FRONTIERS IN PLANT SCIENCE, 2023, 14
  • [26] Low toxicity and high immunogenicity of an inactivated vaccine candidate against COVID-19 in different animal models
    Wang, Ze-Jun
    Zhang, Hua-Jun
    Lu, Jia
    Xu, Kang-Wei
    Peng, Cheng
    Guo, Jing
    Gao, Xiao-Xiao
    Wan, Xin
    Wang, Wen-Hui
    Shan, Chao
    Zhang, Su-Cai
    Wu, Jie
    Yang, An-Na
    Zhu, Yan
    Xiao, Ao
    Zhang, Lei
    Fu, Lie
    Si, Hao-Rui
    Cai, Qian
    Yang, Xing-Lou
    You, Lei
    Zhou, Yan-Ping
    Liu, Jing
    Pang, De-Qing
    Jin, Wei-Ping
    Zhang, Xiao-Yu
    Meng, Sheng-Li
    Sun, Yun-Xia
    Desselberger, Ulrich
    Wang, Jun-Zhi
    Li, Xin-Guo
    Duan, Kai
    Li, Chang-Gui
    Xu, Miao
    Shi, Zheng-Li
    Yuan, Zhi-Ming
    Yang, Xiao-Ming
    Shen, Shuo
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 2606 - 2618
  • [27] Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
    Seyed Mehdi Sadat
    Mohammad Reza Aghadadeghi
    Masoume Yousefi
    Arezoo Khodaei
    Mona Sadat Larijani
    Golnaz Bahramali
    Molecular Biotechnology, 2021, 63 : 389 - 409
  • [28] Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates
    Pillet, Stephane
    Arunachalam, Prabhu S.
    Andreani, Guadalupe
    Golden, Nadia
    Fontenot, Jane
    Aye, Pyone
    Roltgen, Katharina
    Lehmick, Gabrielle
    Dube, Charlotte
    Gobeil, Philipe
    Trepanier, Sonia
    Charland, Nathalie
    D'Aoust, Marc-Andre
    Russell-Lodrigue, Kasi
    Blair, Robert, V
    Boyd, Scott
    Bohm, Rudolph B.
    Rappaport, Jay
    Villinger, Francois
    Landry, Nathalie
    Pulendran, Bali
    Ward, Brian J.
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (02) : 222 - 233
  • [29] An insight into the epitope-based peptide vaccine design strategy and studies against COVID-19
    Topuzogullari, Murat
    Acar, Tayfun
    Arayici, Pelin Pelit
    Ucar, Burcu
    Ugurel, Erennur
    Abamor, Emrah Sefik
    Arasoglu, Tulin
    Turgut-Balik, Dilek
    Derman, Serap
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 215 - 227
  • [30] Rational design of a booster vaccine against COVID-19 based on antigenic distance
    Hu, Ye-Fan
    Yuen, Terrence Tsz-Tai
    Gong, Hua-Rui
    Hu, Bingjie
    Hu, Jing-Chu
    Lin, Xuan-Sheng
    Rong, Li
    Zhou, Coco Luyao
    Chen, Lin-Lei
    Wang, Xiaolei
    Lei, Chaobi
    Yau, Thomas
    Hung, Ivan Fan-Ngai
    To, Kelvin Kai-Wang
    Yuen, Kwok-Yung
    Zhang, Bao-Zhong
    Chu, Hin
    Huang, Jian-Dong
    CELL HOST & MICROBE, 2023, 31 (08) : 1301 - 1316.e8
12345